SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Medical ImagingNuclear Medical

PUBLISHER: Market Glass, Inc. | PRODUCT CODE: 2143631

Cover Image

PUBLISHER: Market Glass, Inc. | PRODUCT CODE: 2143631

Mobile Gamma Cameras

PUBLISHED:
PAGES: 364 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5850
PDF & Excel (Team License: Up to 10 users)
USD 11115
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Mobile Gamma Cameras Market to Reach US$82.4 Thousand by 2032

The global market for Mobile Gamma Cameras estimated at US$62.7 Thousand in the year 2025, is expected to reach US$82.4 Thousand by 2032, growing at a CAGR of 4.0% over the analysis period 2025-2032. Single Head Product, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$31.2 Thousand by the end of the analysis period. Growth in the Double Head Product segment is estimated at 2.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$17.1 Thousand While China is Forecast to Grow at 7.2% CAGR

The Mobile Gamma Cameras market in the U.S. is estimated at US$17.1 Thousand in the year 2025. China, the world's second largest economy, is forecast to reach a projected market size of US$17.1 Thousand by the year 2032 trailing a CAGR of 7.2% over the analysis period 2025-2032. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.7% and 3.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Mobile Gamma Cameras - Key Trends and Drivers

A gamma camera, also known as a scintillation camera, is pivotal for imaging gamma radiation-emitting radioisotopes. This technique, scintigraphy, is essential in nuclear medical imaging and drug development. It helps visualize radionuclide distribution in the body, enhancing diagnosis and treatment. Mobile gamma cameras facilitate bedside diagnostics, offering convenience and improved patient care. Their portability allows for use in remote locations, vital for rural healthcare where imaging equipment is scarce. They require less capital investment than fixed cameras. Multiple facilities can share them, reducing overall costs.

With the increasing incidence of chronic conditions like cancer and cardiovascular diseases, the need for early diagnosis and efficient monitoring has expanded, leading to higher adoption of gamma cameras. Mobile gamma cameras offer cost advantages over traditional fixed units by reducing the need for significant infrastructure investments. They can be shared across multiple facilities, improving accessibility in underserved regions. Gamma cameras play a crucial role in personalized treatment plans, guiding targeted therapies by providing detailed imaging data. Advances in technology have made gamma cameras more compact, portable, and user-friendly, thus increasing their adoption in various clinical settings, especially in rural and resource-constrained areas. The incorporation of wireless data transmission enables real-time data sharing, facilitating remote patient monitoring and quick diagnosis.

Mobile gamma cameras integrated with telehealth systems enable seamless sharing of diagnostic information, improving care in remote and underserved areas. AI and ML are enhancing data analysis and interpretation, helping identify anomalies more accurately and efficiently. Gamma cameras are increasingly used in fields beyond oncology and cardiology, including orthopedics, neurology, and emergency care, due to their portability and accuracy. Technological advances are minimizing patient and staff radiation exposure, addressing a primary concern for mobile gamma cameras. Seamless integration with electronic health records (EHRs) simplifies data management, enabling efficient storage and retrieval. Their mobility allows clinicians to bring diagnostic tools directly to the patient's bedside, reducing delays and improving diagnostic workflows.

SCOPE OF STUDY:

The report analyzes the Mobile Gamma Cameras market by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Single Head Product, Double Head Product, Triple Head Product, Hand Held Product); Indication (Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication, Other Indications); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use, Specialized Clinics End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

SELECT PLAYERS -

  • Ahlberg Cameras, Inc.
  • BASLER AG
  • Canon Medical Systems Corporation
  • Changzhou Minking Electronics Co., Ltd.
  • DDD-Diagnostic A/S
  • Elekta AB
  • GAEDE Medizinsysteme GmbH
  • GameRefinery
  • Philips Healthcare
  • Siemens Healthineers AG

WHAT SETS THIS REPORT APART FROM OTHERS?

Grounded in Domain Expert Perspectives - Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.

Captures Early Market Signals - Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.

Draws From a Broad, Validated Intelligence Base - Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.

Connects Signals With Strategic Market Direction - Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.

Provides In-Depth Company Intelligence - Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.

Market Share Is Examined Where It Matters - A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, Market Glass reports extend market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.

Show more
Product Code: MG3333

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Mobile Gamma Cameras - Global Key Competitors Percentage Market Share in 2026 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for 13 Players Worldwide in 2026 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Miniaturization and Portability Expand Addressable Market Opportunities
    • Enhanced Imaging Capabilities Drive Adoption of Mobile Gamma Cameras
    • Emergency Medicine Accelerates Demand for Mobile Gamma Technologies
    • Remote Patient Monitoring Strengthens Business Case for Mobile Gamma Cameras
    • Integrated Artificial Intelligence Improves Diagnostic Accuracy and Efficiency
    • IoT Connectivity Spurs Innovation and Competitive Differentiation
    • Patient-Centric Designs Highlight Development Trends in Mobile Gamma Cameras
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
    • TABLE 2: World Historic Review for Mobile Gamma Cameras by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 3: World 13-Year Perspective for Mobile Gamma Cameras by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
    • TABLE 4: World Mobile Gamma Cameras Market Analysis of Annual Sales in US$ for Years 2020 through 2032
    • TABLE 5: World Recent Past, Current & Future Analysis for Single Head Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
    • TABLE 6: World Historic Review for Single Head Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 7: World 13-Year Perspective for Single Head Product by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 8: World Recent Past, Current & Future Analysis for Double Head Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
    • TABLE 9: World Historic Review for Double Head Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 10: World 13-Year Perspective for Double Head Product by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 11: World Recent Past, Current & Future Analysis for Triple Head Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
    • TABLE 12: World Historic Review for Triple Head Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 13: World 13-Year Perspective for Triple Head Product by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 14: World Recent Past, Current & Future Analysis for Hand Held Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
    • TABLE 15: World Historic Review for Hand Held Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 16: World 13-Year Perspective for Hand Held Product by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 17: World Recent Past, Current & Future Analysis for Cardiac Imaging Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
    • TABLE 18: World Historic Review for Cardiac Imaging Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 19: World 13-Year Perspective for Cardiac Imaging Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 20: World Recent Past, Current & Future Analysis for Breast Imaging Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
    • TABLE 21: World Historic Review for Breast Imaging Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 22: World 13-Year Perspective for Breast Imaging Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 23: World Recent Past, Current & Future Analysis for Hepatobiliary Imaging Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
    • TABLE 24: World Historic Review for Hepatobiliary Imaging Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 25: World 13-Year Perspective for Hepatobiliary Imaging Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 26: World Recent Past, Current & Future Analysis for GI Imaging Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
    • TABLE 27: World Historic Review for GI Imaging Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 28: World 13-Year Perspective for GI Imaging Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 29: World Recent Past, Current & Future Analysis for Renal Imaging Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
    • TABLE 30: World Historic Review for Renal Imaging Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 31: World 13-Year Perspective for Renal Imaging Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 32: World Recent Past, Current & Future Analysis for Brain Imaging Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
    • TABLE 33: World Historic Review for Brain Imaging Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 34: World 13-Year Perspective for Brain Imaging Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 35: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
    • TABLE 36: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 37: World 13-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 38: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
    • TABLE 39: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 40: World 13-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 41: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
    • TABLE 42: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 43: World 13-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 44: World Recent Past, Current & Future Analysis for Cancer Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
    • TABLE 45: World Historic Review for Cancer Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 46: World 13-Year Perspective for Cancer Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 47: World Recent Past, Current & Future Analysis for Specialized Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
    • TABLE 48: World Historic Review for Specialized Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 49: World 13-Year Perspective for Specialized Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032

III. MARKET ANALYSIS

  • UNITED STATES
    • Mobile Gamma Cameras Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
    • TABLE 50: USA Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 51: USA Historic Review for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 52: USA 13-Year Perspective for Mobile Gamma Cameras by Product - Percentage Breakdown of Value Sales for Single Head Product, Double Head Product, Triple Head Product and Hand Held Product for the Years 2020, 2026 & 2032
    • TABLE 53: USA Recent Past, Current & Future Analysis for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 54: USA Historic Review for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 55: USA 13-Year Perspective for Mobile Gamma Cameras by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use for the Years 2020, 2026 & 2032
    • TABLE 56: USA Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 57: USA Historic Review for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 58: USA 13-Year Perspective for Mobile Gamma Cameras by Indication - Percentage Breakdown of Value Sales for Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • CANADA
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 60: Canada Historic Review for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 61: Canada 13-Year Perspective for Mobile Gamma Cameras by Product - Percentage Breakdown of Value Sales for Single Head Product, Double Head Product, Triple Head Product and Hand Held Product for the Years 2020, 2026 & 2032
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 63: Canada Historic Review for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 64: Canada 13-Year Perspective for Mobile Gamma Cameras by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use for the Years 2020, 2026 & 2032
    • TABLE 65: Canada Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 66: Canada Historic Review for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 67: Canada 13-Year Perspective for Mobile Gamma Cameras by Indication - Percentage Breakdown of Value Sales for Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • JAPAN
    • Mobile Gamma Cameras Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 69: Japan Historic Review for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 70: Japan 13-Year Perspective for Mobile Gamma Cameras by Product - Percentage Breakdown of Value Sales for Single Head Product, Double Head Product, Triple Head Product and Hand Held Product for the Years 2020, 2026 & 2032
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 72: Japan Historic Review for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 73: Japan 13-Year Perspective for Mobile Gamma Cameras by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use for the Years 2020, 2026 & 2032
    • TABLE 74: Japan Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 75: Japan Historic Review for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 76: Japan 13-Year Perspective for Mobile Gamma Cameras by Indication - Percentage Breakdown of Value Sales for Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • CHINA
    • Mobile Gamma Cameras Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
    • TABLE 77: China Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 78: China Historic Review for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 79: China 13-Year Perspective for Mobile Gamma Cameras by Product - Percentage Breakdown of Value Sales for Single Head Product, Double Head Product, Triple Head Product and Hand Held Product for the Years 2020, 2026 & 2032
    • TABLE 80: China Recent Past, Current & Future Analysis for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 81: China Historic Review for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 82: China 13-Year Perspective for Mobile Gamma Cameras by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use for the Years 2020, 2026 & 2032
    • TABLE 83: China Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 84: China Historic Review for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 85: China 13-Year Perspective for Mobile Gamma Cameras by Indication - Percentage Breakdown of Value Sales for Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • EUROPE
    • Mobile Gamma Cameras Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
    • TABLE 87: Europe Historic Review for Mobile Gamma Cameras by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 88: Europe 13-Year Perspective for Mobile Gamma Cameras by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2020, 2026 & 2032
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 90: Europe Historic Review for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 91: Europe 13-Year Perspective for Mobile Gamma Cameras by Product - Percentage Breakdown of Value Sales for Single Head Product, Double Head Product, Triple Head Product and Hand Held Product for the Years 2020, 2026 & 2032
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 93: Europe Historic Review for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 94: Europe 13-Year Perspective for Mobile Gamma Cameras by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use for the Years 2020, 2026 & 2032
    • TABLE 95: Europe Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 96: Europe Historic Review for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 97: Europe 13-Year Perspective for Mobile Gamma Cameras by Indication - Percentage Breakdown of Value Sales for Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • FRANCE
    • Mobile Gamma Cameras Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
    • TABLE 98: France Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 99: France Historic Review for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 100: France 13-Year Perspective for Mobile Gamma Cameras by Product - Percentage Breakdown of Value Sales for Single Head Product, Double Head Product, Triple Head Product and Hand Held Product for the Years 2020, 2026 & 2032
    • TABLE 101: France Recent Past, Current & Future Analysis for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 102: France Historic Review for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 103: France 13-Year Perspective for Mobile Gamma Cameras by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use for the Years 2020, 2026 & 2032
    • TABLE 104: France Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 105: France Historic Review for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 106: France 13-Year Perspective for Mobile Gamma Cameras by Indication - Percentage Breakdown of Value Sales for Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • GERMANY
    • Mobile Gamma Cameras Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 108: Germany Historic Review for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 109: Germany 13-Year Perspective for Mobile Gamma Cameras by Product - Percentage Breakdown of Value Sales for Single Head Product, Double Head Product, Triple Head Product and Hand Held Product for the Years 2020, 2026 & 2032
    • TABLE 110: Germany Recent Past, Current & Future Analysis for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 111: Germany Historic Review for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 112: Germany 13-Year Perspective for Mobile Gamma Cameras by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use for the Years 2020, 2026 & 2032
    • TABLE 113: Germany Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 114: Germany Historic Review for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 115: Germany 13-Year Perspective for Mobile Gamma Cameras by Indication - Percentage Breakdown of Value Sales for Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • ITALY
    • TABLE 116: Italy Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 117: Italy Historic Review for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 118: Italy 13-Year Perspective for Mobile Gamma Cameras by Product - Percentage Breakdown of Value Sales for Single Head Product, Double Head Product, Triple Head Product and Hand Held Product for the Years 2020, 2026 & 2032
    • TABLE 119: Italy Recent Past, Current & Future Analysis for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 120: Italy Historic Review for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 121: Italy 13-Year Perspective for Mobile Gamma Cameras by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use for the Years 2020, 2026 & 2032
    • TABLE 122: Italy Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 123: Italy Historic Review for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 124: Italy 13-Year Perspective for Mobile Gamma Cameras by Indication - Percentage Breakdown of Value Sales for Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • UNITED KINGDOM
    • Mobile Gamma Cameras Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
    • TABLE 125: UK Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 126: UK Historic Review for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 127: UK 13-Year Perspective for Mobile Gamma Cameras by Product - Percentage Breakdown of Value Sales for Single Head Product, Double Head Product, Triple Head Product and Hand Held Product for the Years 2020, 2026 & 2032
    • TABLE 128: UK Recent Past, Current & Future Analysis for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 129: UK Historic Review for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 130: UK 13-Year Perspective for Mobile Gamma Cameras by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use for the Years 2020, 2026 & 2032
    • TABLE 131: UK Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 132: UK Historic Review for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 133: UK 13-Year Perspective for Mobile Gamma Cameras by Indication - Percentage Breakdown of Value Sales for Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • SPAIN
    • TABLE 134: Spain Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 135: Spain Historic Review for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 136: Spain 13-Year Perspective for Mobile Gamma Cameras by Product - Percentage Breakdown of Value Sales for Single Head Product, Double Head Product, Triple Head Product and Hand Held Product for the Years 2020, 2026 & 2032
    • TABLE 137: Spain Recent Past, Current & Future Analysis for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 138: Spain Historic Review for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 139: Spain 13-Year Perspective for Mobile Gamma Cameras by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use for the Years 2020, 2026 & 2032
    • TABLE 140: Spain Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 141: Spain Historic Review for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 142: Spain 13-Year Perspective for Mobile Gamma Cameras by Indication - Percentage Breakdown of Value Sales for Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • RUSSIA
    • TABLE 143: Russia Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 144: Russia Historic Review for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 145: Russia 13-Year Perspective for Mobile Gamma Cameras by Product - Percentage Breakdown of Value Sales for Single Head Product, Double Head Product, Triple Head Product and Hand Held Product for the Years 2020, 2026 & 2032
    • TABLE 146: Russia Recent Past, Current & Future Analysis for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 147: Russia Historic Review for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 148: Russia 13-Year Perspective for Mobile Gamma Cameras by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use for the Years 2020, 2026 & 2032
    • TABLE 149: Russia Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 150: Russia Historic Review for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 151: Russia 13-Year Perspective for Mobile Gamma Cameras by Indication - Percentage Breakdown of Value Sales for Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • REST OF EUROPE
    • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 153: Rest of Europe Historic Review for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 154: Rest of Europe 13-Year Perspective for Mobile Gamma Cameras by Product - Percentage Breakdown of Value Sales for Single Head Product, Double Head Product, Triple Head Product and Hand Held Product for the Years 2020, 2026 & 2032
    • TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 156: Rest of Europe Historic Review for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 157: Rest of Europe 13-Year Perspective for Mobile Gamma Cameras by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use for the Years 2020, 2026 & 2032
    • TABLE 158: Rest of Europe Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 159: Rest of Europe Historic Review for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 160: Rest of Europe 13-Year Perspective for Mobile Gamma Cameras by Indication - Percentage Breakdown of Value Sales for Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • ASIA-PACIFIC
    • Mobile Gamma Cameras Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Mobile Gamma Cameras by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 163: Asia-Pacific 13-Year Perspective for Mobile Gamma Cameras by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2020, 2026 & 2032
    • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 165: Asia-Pacific Historic Review for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 166: Asia-Pacific 13-Year Perspective for Mobile Gamma Cameras by Product - Percentage Breakdown of Value Sales for Single Head Product, Double Head Product, Triple Head Product and Hand Held Product for the Years 2020, 2026 & 2032
    • TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 168: Asia-Pacific Historic Review for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 169: Asia-Pacific 13-Year Perspective for Mobile Gamma Cameras by Indication - Percentage Breakdown of Value Sales for Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
    • TABLE 170: Asia-Pacific Recent Past, Current & Future Analysis for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 171: Asia-Pacific Historic Review for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 172: Asia-Pacific 13-Year Perspective for Mobile Gamma Cameras by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use for the Years 2020, 2026 & 2032
  • AUSTRALIA
    • Mobile Gamma Cameras Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
    • TABLE 173: Australia Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 174: Australia Historic Review for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 175: Australia 13-Year Perspective for Mobile Gamma Cameras by Product - Percentage Breakdown of Value Sales for Single Head Product, Double Head Product, Triple Head Product and Hand Held Product for the Years 2020, 2026 & 2032
    • TABLE 176: Australia Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 177: Australia Historic Review for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 178: Australia 13-Year Perspective for Mobile Gamma Cameras by Indication - Percentage Breakdown of Value Sales for Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
    • TABLE 179: Australia Recent Past, Current & Future Analysis for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 180: Australia Historic Review for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 181: Australia 13-Year Perspective for Mobile Gamma Cameras by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use for the Years 2020, 2026 & 2032
  • INDIA
    • Mobile Gamma Cameras Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
    • TABLE 182: India Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 183: India Historic Review for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 184: India 13-Year Perspective for Mobile Gamma Cameras by Product - Percentage Breakdown of Value Sales for Single Head Product, Double Head Product, Triple Head Product and Hand Held Product for the Years 2020, 2026 & 2032
    • TABLE 185: India Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 186: India Historic Review for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 187: India 13-Year Perspective for Mobile Gamma Cameras by Indication - Percentage Breakdown of Value Sales for Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
    • TABLE 188: India Recent Past, Current & Future Analysis for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 189: India Historic Review for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 190: India 13-Year Perspective for Mobile Gamma Cameras by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use for the Years 2020, 2026 & 2032
  • SOUTH KOREA
    • TABLE 191: South Korea Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 192: South Korea Historic Review for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 193: South Korea 13-Year Perspective for Mobile Gamma Cameras by Product - Percentage Breakdown of Value Sales for Single Head Product, Double Head Product, Triple Head Product and Hand Held Product for the Years 2020, 2026 & 2032
    • TABLE 194: South Korea Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 195: South Korea Historic Review for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 196: South Korea 13-Year Perspective for Mobile Gamma Cameras by Indication - Percentage Breakdown of Value Sales for Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
    • TABLE 197: South Korea Recent Past, Current & Future Analysis for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 198: South Korea Historic Review for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 199: South Korea 13-Year Perspective for Mobile Gamma Cameras by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use for the Years 2020, 2026 & 2032
  • REST OF ASIA-PACIFIC
    • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 201: Rest of Asia-Pacific Historic Review for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 202: Rest of Asia-Pacific 13-Year Perspective for Mobile Gamma Cameras by Product - Percentage Breakdown of Value Sales for Single Head Product, Double Head Product, Triple Head Product and Hand Held Product for the Years 2020, 2026 & 2032
    • TABLE 203: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 204: Rest of Asia-Pacific Historic Review for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 205: Rest of Asia-Pacific 13-Year Perspective for Mobile Gamma Cameras by Indication - Percentage Breakdown of Value Sales for Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
    • TABLE 206: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 207: Rest of Asia-Pacific Historic Review for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 208: Rest of Asia-Pacific 13-Year Perspective for Mobile Gamma Cameras by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use for the Years 2020, 2026 & 2032
  • LATIN AMERICA
    • Mobile Gamma Cameras Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
    • TABLE 209: Latin America Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
    • TABLE 210: Latin America Historic Review for Mobile Gamma Cameras by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 211: Latin America 13-Year Perspective for Mobile Gamma Cameras by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2020, 2026 & 2032
    • TABLE 212: Latin America Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 213: Latin America Historic Review for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 214: Latin America 13-Year Perspective for Mobile Gamma Cameras by Product - Percentage Breakdown of Value Sales for Single Head Product, Double Head Product, Triple Head Product and Hand Held Product for the Years 2020, 2026 & 2032
    • TABLE 215: Latin America Recent Past, Current & Future Analysis for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 216: Latin America Historic Review for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 217: Latin America 13-Year Perspective for Mobile Gamma Cameras by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use for the Years 2020, 2026 & 2032
    • TABLE 218: Latin America Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 219: Latin America Historic Review for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 220: Latin America 13-Year Perspective for Mobile Gamma Cameras by Indication - Percentage Breakdown of Value Sales for Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • ARGENTINA
    • TABLE 221: Argentina Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 222: Argentina Historic Review for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 223: Argentina 13-Year Perspective for Mobile Gamma Cameras by Product - Percentage Breakdown of Value Sales for Single Head Product, Double Head Product, Triple Head Product and Hand Held Product for the Years 2020, 2026 & 2032
    • TABLE 224: Argentina Recent Past, Current & Future Analysis for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 225: Argentina Historic Review for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 226: Argentina 13-Year Perspective for Mobile Gamma Cameras by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use for the Years 2020, 2026 & 2032
    • TABLE 227: Argentina Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 228: Argentina Historic Review for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 229: Argentina 13-Year Perspective for Mobile Gamma Cameras by Indication - Percentage Breakdown of Value Sales for Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • BRAZIL
    • TABLE 230: Brazil Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 231: Brazil Historic Review for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 232: Brazil 13-Year Perspective for Mobile Gamma Cameras by Product - Percentage Breakdown of Value Sales for Single Head Product, Double Head Product, Triple Head Product and Hand Held Product for the Years 2020, 2026 & 2032
    • TABLE 233: Brazil Recent Past, Current & Future Analysis for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 234: Brazil Historic Review for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 235: Brazil 13-Year Perspective for Mobile Gamma Cameras by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use for the Years 2020, 2026 & 2032
    • TABLE 236: Brazil Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 237: Brazil Historic Review for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 238: Brazil 13-Year Perspective for Mobile Gamma Cameras by Indication - Percentage Breakdown of Value Sales for Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • MEXICO
    • TABLE 239: Mexico Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 240: Mexico Historic Review for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 241: Mexico 13-Year Perspective for Mobile Gamma Cameras by Product - Percentage Breakdown of Value Sales for Single Head Product, Double Head Product, Triple Head Product and Hand Held Product for the Years 2020, 2026 & 2032
    • TABLE 242: Mexico Recent Past, Current & Future Analysis for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 243: Mexico Historic Review for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 244: Mexico 13-Year Perspective for Mobile Gamma Cameras by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use for the Years 2020, 2026 & 2032
    • TABLE 245: Mexico Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 246: Mexico Historic Review for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 247: Mexico 13-Year Perspective for Mobile Gamma Cameras by Indication - Percentage Breakdown of Value Sales for Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • REST OF LATIN AMERICA
    • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 249: Rest of Latin America Historic Review for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 250: Rest of Latin America 13-Year Perspective for Mobile Gamma Cameras by Product - Percentage Breakdown of Value Sales for Single Head Product, Double Head Product, Triple Head Product and Hand Held Product for the Years 2020, 2026 & 2032
    • TABLE 251: Rest of Latin America Recent Past, Current & Future Analysis for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 252: Rest of Latin America Historic Review for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 253: Rest of Latin America 13-Year Perspective for Mobile Gamma Cameras by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use for the Years 2020, 2026 & 2032
    • TABLE 254: Rest of Latin America Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 255: Rest of Latin America Historic Review for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 256: Rest of Latin America 13-Year Perspective for Mobile Gamma Cameras by Indication - Percentage Breakdown of Value Sales for Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • MIDDLE EAST
    • Mobile Gamma Cameras Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
    • TABLE 257: Middle East Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
    • TABLE 258: Middle East Historic Review for Mobile Gamma Cameras by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 259: Middle East 13-Year Perspective for Mobile Gamma Cameras by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2020, 2026 & 2032
    • TABLE 260: Middle East Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 261: Middle East Historic Review for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 262: Middle East 13-Year Perspective for Mobile Gamma Cameras by Product - Percentage Breakdown of Value Sales for Single Head Product, Double Head Product, Triple Head Product and Hand Held Product for the Years 2020, 2026 & 2032
    • TABLE 263: Middle East Recent Past, Current & Future Analysis for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 264: Middle East Historic Review for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 265: Middle East 13-Year Perspective for Mobile Gamma Cameras by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use for the Years 2020, 2026 & 2032
    • TABLE 266: Middle East Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 267: Middle East Historic Review for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 268: Middle East 13-Year Perspective for Mobile Gamma Cameras by Indication - Percentage Breakdown of Value Sales for Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • IRAN
    • TABLE 269: Iran Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 270: Iran Historic Review for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 271: Iran 13-Year Perspective for Mobile Gamma Cameras by Product - Percentage Breakdown of Value Sales for Single Head Product, Double Head Product, Triple Head Product and Hand Held Product for the Years 2020, 2026 & 2032
    • TABLE 272: Iran Recent Past, Current & Future Analysis for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 273: Iran Historic Review for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 274: Iran 13-Year Perspective for Mobile Gamma Cameras by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use for the Years 2020, 2026 & 2032
    • TABLE 275: Iran Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 276: Iran Historic Review for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 277: Iran 13-Year Perspective for Mobile Gamma Cameras by Indication - Percentage Breakdown of Value Sales for Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • ISRAEL
    • TABLE 278: Israel Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 279: Israel Historic Review for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 280: Israel 13-Year Perspective for Mobile Gamma Cameras by Product - Percentage Breakdown of Value Sales for Single Head Product, Double Head Product, Triple Head Product and Hand Held Product for the Years 2020, 2026 & 2032
    • TABLE 281: Israel Recent Past, Current & Future Analysis for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 282: Israel Historic Review for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 283: Israel 13-Year Perspective for Mobile Gamma Cameras by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use for the Years 2020, 2026 & 2032
    • TABLE 284: Israel Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 285: Israel Historic Review for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 286: Israel 13-Year Perspective for Mobile Gamma Cameras by Indication - Percentage Breakdown of Value Sales for Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • SAUDI ARABIA
    • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 288: Saudi Arabia Historic Review for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 289: Saudi Arabia 13-Year Perspective for Mobile Gamma Cameras by Product - Percentage Breakdown of Value Sales for Single Head Product, Double Head Product, Triple Head Product and Hand Held Product for the Years 2020, 2026 & 2032
    • TABLE 290: Saudi Arabia Recent Past, Current & Future Analysis for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 291: Saudi Arabia Historic Review for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 292: Saudi Arabia 13-Year Perspective for Mobile Gamma Cameras by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use for the Years 2020, 2026 & 2032
    • TABLE 293: Saudi Arabia Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 294: Saudi Arabia Historic Review for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 295: Saudi Arabia 13-Year Perspective for Mobile Gamma Cameras by Indication - Percentage Breakdown of Value Sales for Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • UNITED ARAB EMIRATES
    • TABLE 296: UAE Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 297: UAE Historic Review for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 298: UAE 13-Year Perspective for Mobile Gamma Cameras by Product - Percentage Breakdown of Value Sales for Single Head Product, Double Head Product, Triple Head Product and Hand Held Product for the Years 2020, 2026 & 2032
    • TABLE 299: UAE Recent Past, Current & Future Analysis for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 300: UAE Historic Review for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 301: UAE 13-Year Perspective for Mobile Gamma Cameras by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use for the Years 2020, 2026 & 2032
    • TABLE 302: UAE Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 303: UAE Historic Review for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 304: UAE 13-Year Perspective for Mobile Gamma Cameras by Indication - Percentage Breakdown of Value Sales for Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • REST OF MIDDLE EAST
    • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 306: Rest of Middle East Historic Review for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 307: Rest of Middle East 13-Year Perspective for Mobile Gamma Cameras by Product - Percentage Breakdown of Value Sales for Single Head Product, Double Head Product, Triple Head Product and Hand Held Product for the Years 2020, 2026 & 2032
    • TABLE 308: Rest of Middle East Recent Past, Current & Future Analysis for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 309: Rest of Middle East Historic Review for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 310: Rest of Middle East 13-Year Perspective for Mobile Gamma Cameras by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use for the Years 2020, 2026 & 2032
    • TABLE 311: Rest of Middle East Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 312: Rest of Middle East Historic Review for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 313: Rest of Middle East 13-Year Perspective for Mobile Gamma Cameras by Indication - Percentage Breakdown of Value Sales for Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • AFRICA
    • Mobile Gamma Cameras Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
    • TABLE 314: Africa Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 315: Africa Historic Review for Mobile Gamma Cameras by Product - Single Head Product, Double Head Product, Triple Head Product and Hand Held Product Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 316: Africa 13-Year Perspective for Mobile Gamma Cameras by Product - Percentage Breakdown of Value Sales for Single Head Product, Double Head Product, Triple Head Product and Hand Held Product for the Years 2020, 2026 & 2032
    • TABLE 317: Africa Recent Past, Current & Future Analysis for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 318: Africa Historic Review for Mobile Gamma Cameras by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 319: Africa 13-Year Perspective for Mobile Gamma Cameras by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cancer Research Institutes End-Use and Specialized Clinics End-Use for the Years 2020, 2026 & 2032
    • TABLE 320: Africa Recent Past, Current & Future Analysis for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 321: Africa Historic Review for Mobile Gamma Cameras by Indication - Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 322: Africa 13-Year Perspective for Mobile Gamma Cameras by Indication - Percentage Breakdown of Value Sales for Cardiac Imaging Indication, Breast Imaging Indication, Hepatobiliary Imaging Indication, GI Imaging Indication, Renal Imaging Indication, Brain Imaging Indication and Other Indications for the Years 2020, 2026 & 2032

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!